Turk Kardiyol Dern Ars. 2012; 40(4): 323-330 | DOI: 10.5543/tkda.2012.59144
Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey
, Coskun İkizler2
, Atilla Sengul3
, Bilal Çuğlan4
, Elizabeth Kennard5
, Sheryl Kelsey51
University of Pittsburgh, Heart And Vascular İnstitute 200 Lothrop Street Presbyterian Hospital, Upmc, 7th Floor, F-748 Pittsburgh, Pa, 15044 Usa2
Department of Cardiovascular Surgery, Medical School, Ufuk University, Ankara, Turkey3
MEDKAR Heart Diagnosis And Treatment Center, Ankara, Turkey4
Department of Cardiology, İnönü University, Turgut Özal Medical Center, Malatya, Turkey.5
Department of Epidemiology, Graduate School of Public Health, University Of Pittsburgh, Pittsburgh, Pennsylvannia, Usa
OBJECTIVES This study assessed the long-term efficacy of EECP (Enhanced External Counterpulsation) in Turkish (TR) patients initially and compared these results with the United States (US) in a real world setting.
STUDY DESIGN In this study, 2072 patients were treated and followed in the US and 82 patients were treated and followed in TR. The International EECP Patient Registry Phase I and II was initiated and coordinated at the University of Pittsburgh. The aim of the registry was to assess the outcomes of clinical trials in a real world setting. Another unique feature of this study was to enroll patients not only from university hospitals but also from private hospitals, educational hospitals, and treatment centers.
RESULTS TR patients had less diabetes, hypertension, and hyperlipidemia than US patients (p<0.01). TR patients also had a higher proportion of diastolic augmentation (p<0.001). Both groups showed a significant reduction in the severity of angina after a 35h EECP course (p<0.001). Major Adverse Cardiac Events (MACE) rate (death, coronary artery bypass graft, percutaneous coronary intervention, myocardial infarction) was low in both groups during treatment (2.5% vs. 2.7%). At 1 year follow up, 84% of TR and 76% of US patients had maintained the improvement of angina.
CONCLUSION Patients presenting for EECP treatment from TR had different baseline profiles from US patients. However, despite the high risk baseline characteristics, both cohorts achieved similar reduction in angina. In the long term follow-up, the MACE rate was low and the improvement after EECP was sustained in most of the patients.
Aged, angina pectoris/mortality/therapy, coronary artery disease/epidemiology, counterpulsation/methods, enhanced external counterpulsation; follow-up studies; heart failure/epidemiology; registries; treatment outcome; Turkey/epidemiology
How to cite this article
Ozlem Soran, Coskun İkizler, Atilla Sengul, Bilal Çuğlan, Elizabeth Kennard, Sheryl Kelsey. Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. Turk Kardiyol Dern Ars. 2012; 40(4): 323-330
Corresponding Author: Ozlem Soran, United States